04/25/2024 6:10 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Necina Roman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Kandera Reinhard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Winderlich Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Aldag Jorn (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Orlinger Klaus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 3:19 PM | Hookipa Pharma (Issuer) Winderlich Mark (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
|
03/22/2024 6:33 AM | Hookipa Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/22/2024 6:08 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 4:47 PM | Hookipa Pharma (Subject)
| Form SC 13G/A | |
02/14/2024 4:47 PM | EcoR1 Capital, LLC (Filed by) EcoR1 Capital, LLC (Filed by) Hookipa Pharma (Subject)
| Form SC 13G/A | |
01/31/2024 3:30 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 7:12 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 11:15 PM | Hookipa Pharma (Filer)
| Form EFFECT | |
12/22/2023 3:07 PM | GILEAD SCIENCES, INC. (Reporting) Hookipa Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2023 6:33 AM | Hookipa Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/21/2023 6:06 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 3:46 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:05 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:10 AM | Hookipa Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023 3:05 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 7:47 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2023 7:01 AM | Hookipa Pharma (Subject)
| Form SC TO-I/A | |
09/11/2023 7:23 AM | FMR LLC (Filed by) Hookipa Pharma (Subject)
| Form SC 13G/A | |
08/10/2023 6:05 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 6:07 AM | Hookipa Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023 5:21 PM | Aldag Jorn (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 4:06 PM | Aldag Jorn (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 6:37 PM | Aldag Jorn (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:06 PM | Hookipa Pharma (Issuer) Kandera Reinhard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 10:04 AM | Hookipa Pharma (Subject) Knoll Capital Management, LLC (Filed by)
| Form SC 13G | |
06/09/2023 4:13 PM | Coelho Mary Theresa (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:13 PM | Hookipa Pharma (Issuer) Kaufman David Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:14 PM | Hookipa Pharma (Issuer) van de Winkel Jan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:15 PM | Hookipa Pharma (Issuer) O'Neill Julie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:16 PM | Hookipa Pharma (Issuer) Reilly Timothy P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:16 PM | Hookipa Pharma (Issuer) Peters Malte (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 4:17 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 4:24 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 6:03 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 6:14 AM | Hookipa Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
1970’s computer coder Issues Shocking AI Warning (Ad) Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology…
Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans. Click here to watch his new video ASAP |